Generic entry, price competition, and market segmentation in the prescription drug market
- 31 July 2008
- journal article
- Published by Elsevier in International Journal of Industrial Organization
- Vol. 26 (4) , 930-948
- https://doi.org/10.1016/j.ijindorg.2007.08.004
Abstract
No abstract availableKeywords
All Related Versions
This publication has 28 references indexed in Scilit:
- Solutions to Problems Posed in Volume 20(1) and 20(2): 04.1.1. A Hausman Test Based on the Difference between Fixed Effects Two-Stage Least Squares and Error Components Two-Stage Least Squares—SolutionEconometric Theory, 2005
- 04.1.1. A Hausman Test Based on the Difference between Fixed Effects Two-Stage Least Squares and Error Components Two-Stage Least SquaresEconometric Theory, 2004
- The Relative Importance of Actual and Potential Competition: Empirical Evidence From the Pharmaceuticals MarketJournal of Industrial Economics, 2003
- The Long Shadow of Patent ExpirationPublished by University of Chicago Press ,2003
- Pharmaceuticals in U.S. Health Care: Determinants of Quantity and PriceJournal of Economic Perspectives, 2002
- The Importance of Doctors’ and Patients’ Preferences in the Prescription DecisionJournal of Industrial Economics, 2000
- SIMULTANEOUS EQUATIONS WITH INCOMPLETE PANELSEconometric Theory, 2000
- Incomplete panelsJournal of Econometrics, 1994
- Simultaneous equations with error componentsJournal of Econometrics, 1981
- Pricing Pioneering ProductsJournal of Industrial Economics, 1969